Abdurrahman Goran, Samukange Washington, Lyoko Nyambe, Shonhiwa Negus Onai, Kafere Chancelar, Nübling C Micha, Peeling Rosanna W, Reinhardt Jens
TÜV Rheinland LGA Products GmbH, Cologne, Germany.
Paul-Ehrlich-Institut, Langen, Germany.
Front Med (Lausanne). 2023 Oct 3;10:1252721. doi: 10.3389/fmed.2023.1252721. eCollection 2023.
According to the World Health Organization, blood must be screened for major transmitted infections before transfusion to prevent the possibility of passing an infection to the recipient. For accurate detection of infectious disease pathogens in the blood of donors, diagnostic medical devices (IVDs) of high specificity and sensitivity should be used. In mature healthcare systems, the regulatory authorities authorize the usage of devices with the highest performance capabilities, which are also controlled through active market oversight. However, in Sub-Saharan African countries, the regulation of IVDs is often poorly developed. With the lack of stringent regulatory oversight, IVDs of poor quality can be put on the market and used for blood donor screening, which, ultimately, poses a great public health threat. The BloodTrain is a humanitarian project from the Germany Federal Ministry of Health that aims to help strengthen the regulatory authorities in Sub-Saharan partner countries. Here, we present the status of IVD regulation in the partner countries and the objectives that the BloodTrain project aims to achieve in the region toward regulating IVDs.
根据世界卫生组织的要求,输血前必须对血液进行主要传播感染筛查,以防止将感染传播给受血者。为准确检测献血者血液中的传染病病原体,应使用高特异性和高灵敏度的诊断医疗设备(IVD)。在成熟的医疗体系中,监管机构会批准使用性能最佳的设备,这些设备也会通过积极的市场监管加以管控。然而,在撒哈拉以南非洲国家,IVD的监管往往很不完善。由于缺乏严格的监管,质量不佳的IVD可能会投放市场并用于献血者筛查,这最终会对公众健康构成巨大威胁。“血液列车”是德国联邦卫生部发起的一个人道主义项目,旨在帮助加强撒哈拉以南非洲伙伴国家的监管机构。在此,我们介绍伙伴国家IVD监管的现状以及“血液列车”项目在该地区监管IVD方面旨在实现的目标。